Toggle navigation
Home
Search
Services
Blog
Contact
About
Peroxisome Biogenesis, Normal and Deficient
Balfe, Alan M.
Kennedy Krieger Research Institute, Inc., Baltimore, MD, United States
Search grants from Alan Balfe
Search grants from Kennedy Krieger Research Institute, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
(PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors
Molecular mechanisms of synapse assembly and function
Abeta and Monoaminergic Neurodegeneration in Transgenic Mouse Models of AD
Delivery of Biopolymers Using Cationic Peptides
Research Training in Medical Informatics
Recently added grants:
Molecular Mechanisms of Semaphorin/Plexin-mediated Cytoskeletal Reorganization
Behavioral and mechanistic dissection of a cognitive thalamo-cortical network
Cellular and Circuit Mechanisms of Temporal Lobe Epilepsy
Mechanisms of mitochondrial disease suppression in Ndufs4 knockout mice
Molecular Genetics of Synaptic Plasticity
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
International Research Fellowships (FIC) (F05)
Project #
1F05TW003908-01
Application #
3021253
Study Section
(BI)
Project Start
1988-06-30
Project End
Budget Start
1987-11-01
Budget End
1988-10-31
Support Year
1
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Kennedy Krieger Research Institute, Inc.
Department
Type
DUNS #
City
Baltimore
State
MD
Country
United States
Zip Code
21205
Related projects
NIH 1989
F05 TW
Peroxisome Biogenesis, Normal and Deficient
Balfe, Alan M. / Kennedy Krieger Research Institute, Inc.
NIH 1987
F05 TW
Peroxisome Biogenesis, Normal and Deficient
Balfe, Alan M. / Kennedy Krieger Research Institute, Inc.
Publications
Watkins, P A; Chen, W W; Harris, C J et al.
(1989)
Peroxisomal bifunctional enzyme deficiency.
J Clin Invest 83:771-7
Comments
Be the first to comment on this grant